Alexey Repik
Place
-
Now21st
-
Last week27th
-
Two weeks ago26th
-
Three weeks ago26th
- Name
- Alexey Repik
- Net Worth
- 2.8 Billion USD
- Birth Date
- 27 August 1979
- Age
- 45
- Country
- Russia
- City
- Moscow
- Business
- Healthcare
Alexey Repik is a prominent billionaire from Russia, known for his significant contributions to the pharmaceutical and healthcare industries, as well as his active involvement in public service and business advocacy. Born in 1972, Repik began his career in the pharmaceutical sector and quickly rose to prominence as a key figure in Russia's healthcare landscape.
Repik is the founder and Chairman of the Board of Directors of R-Pharm, a leading Russian pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Under his leadership, R-Pharm has grown into one of the largest pharmaceutical companies in Russia and the broader Eurasian region. The company focuses on a wide range of therapeutic areas, including oncology, infectious diseases, and cardiovascular health.
In addition to his success in business, Alexey Repik is actively involved in various public and professional organizations. He is the President of the All-Russian Public Organization "Business Russia," which advocates for the interests of Russian businesses and promotes economic development. Repik's leadership in Business Russia has been instrumental in fostering entrepreneurship, innovation, and sustainable business practices across industries.
Beyond his corporate and advocacy roles, Repik is committed to philanthropy and social responsibility. He supports initiatives aimed at improving healthcare access, education, and cultural development in Russia. His contributions to charitable causes reflect his dedication to making a positive impact on society and enhancing the quality of life for communities in need.
Alexey Repik's career exemplifies entrepreneurial spirit, strategic vision, and a commitment to advancing healthcare and economic prosperity in Russia. His leadership in the pharmaceutical sector and his advocacy for business development have positioned him as a influential figure in both business and public service arenas.
Share
Your involvement